Carcinogenesis, Vol 19, 2163-2168, Copyright © 1998 by Oxford University Press
J Westendorf, W Pfau and A Schulte
Madder root, Rubia tinctorum L., is a traditional herbal medicine used
against kidney stones. Recently we reported that lucidin, a
hydroxyanthraquinone derivative present in this plant, is mutagenic in
bacteria and mammalian cells. We also demonstrated the formation of DNA
adducts in tissue culture and mice after treatment with this compound. To
elucidate the possible carcinogenicity of madder root, three groups of male
and female ACI rats received either a normal diet or a diet supplemented
with 1 or 10% drug for a total period of 780 days. Weight gain and
morbidity were not different among the three groups. Non- neoplastic
lesions related to the treatment were evident in the liver and kidneys of
both sexes. Moreover, dose-dependent increases in benign and malignant
tumour formation were observed in the liver and kidneys of treated animals.
32P-post-labelling analysis showed an increase in the overall level of DNA
adducts observed in the liver, kidney and colon of rats treated with 10%
madder root in the diet for 2 weeks. HPLC analysis of 32P-labelled DNA
adducts revealed a peak co-migrating with an adduct obtained after in vitro
treatment of deoxyguanosine-3'- phosphate with lucidin. These observations
suggest that the use of madder root for medicinal purposes is associated
with a carcinogenic risk.
ARTICLES
Carcinogenicity and DNA adduct formation observed in ACI rats after long-term treatment with madder root, Rubia tinctorum L
Department of Toxicology, University Medical School, Hamburg, Germany. westendorf@uke.uni-hamburg.de
![]()
CiteULike
Connotea
Del.icio.us What's this?